[EN] DERIVATIVES OF SULINDAC CAN PROTECT NORMAL CELLS AGAINST OXIDATIVE DAMAGE [FR] DÉRIVÉS DE SULINDAC APTES À PROTÉGER DES CELLULES NORMALES CONTRE LE STRESS OXYDATIF
Correlation of Hydrolysis and Desilylation of 2-[(Trimethylsilyl)methyl]acrylate Derivatives in Aqueous Alkali Solutions
作者:Chiaki Kuroda、Takeshi Sunakawa、Yuichi Muguruma
DOI:10.1002/hlca.200890093
日期:2008.5
Hydrolysis and desilylation reaction of 2-[(trimethylsilyl)methyl]acrylate (=2-[(trimethylsilyl)methyl]prop-2-enoate) derivatives were studied to evaluate the effect of the presence/absence of a further conjugating substituent (Schemes 3 and 4 and Tables 1 and 2). The substrates having a nonconjugating substituent at the acrylate moiety were stable to dilute alkali conditions, and afforded simple hydrolysis
Derivatives of sulindac can protect normal cells against oxidative damage
申请人:University of South Alabama
公开号:US11186534B2
公开(公告)日:2021-11-30
The disclosure provides chemical compounds possessing therapeutic and/or protective properties against oxidative damage. Methods of making such therapeutic and/or protective compounds and associated compositions are also provided, as are methods for their use, which include protecting cells from oxidative damage and/or inhibiting production of ROS in a cell or subject, as well as preventing or reducing the extent of tissue damage caused by an ischemic event in a subject at elevated risk of such an event.
A New Synthesis of Unsaturated Acids. IV. Further Aspects of the Scope and Mechanism of the Conversion of Halopyrazolones to α,β-Acetylenic and Olefinic Acids<sup>1</sup>
作者:Louis A. Carpino、Paul H. Terry、S. D. Thatte
DOI:10.1021/jo01347a031
日期:1966.9
Fusco; Rossi, Gazzetta Chimica Italiana, 1948, vol. 78, p. 524,533
作者:Fusco、Rossi
DOI:——
日期:——
DERIVATIVES OF SULINDAC CAN PROTECT NORMAL CELLS AGAINST OXIDATIVE DAMAGE
申请人:University of South Alabama
公开号:US20200095184A1
公开(公告)日:2020-03-26
The disclosure provides chemical compounds possessing therapeutic and/or protective properties against oxidative damage. Methods of making such therapeutic and/or protective compounds and associated compositions are also provided, as are methods for their use, which include protecting cells from oxidative damage and/or inhibiting production of ROS in a cell or subject, as well as preventing or reducing the extent of tissue damage caused by an ischemic event in a subject at elevated risk of such an event.